News

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.

A scientific team co-led by Dr. Lishomwa Ndhlovu at Weill Cornell Medicine has received an NIH MERIT Award to provide long-term grant support to study several people who have managed to clear HIV after a stem cell transplant and those who did not.

The award recognizes Dr. Greenblatt's discovery of distinct types of bone-building stem cells in different parts of the body. 

Along with an international team, Dr. John Moore, has brought biomedicine closer than ever to an HIV vaccine.

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find ways to remove latent HIV from the cells of individuals with HIV.

Neurons in the gut produce a molecule that plays a pivotal role in shaping the gut’s immune response during and after inflammation, according to a new study by Weill Cornell Medicine investigators.

Weill Cornell Medicine faculty member Dr. Anna Nam and postdoctoral fellow Dr. Maria Cecelia Lira have been chosen to join the 2025 class of Pew scholars and fellows.

In this new role, Dr. Kaushal will help Weill Cornell Medicine harness data science opportunities in service of better patient outcomes.

An esteemed physician, administrator and teacher, Dr. Alonso served both institutions with distinction for more than 40 years.

COVID-19 prevention methods such as masking and social distancing also suppressed the circulation of common respiratory diseases, leaving young children lacking immunity to pathogens they otherwise would have been exposed to.

Awards, honors and achievements for the month of July.

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A new study reveals that some men who are diagnosed with “Grade Group one” (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University Hospitals Cleveland and Case Western University.

Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin.

The grant supports the launch of a natural history study for a rare neurodevelopmental disorder that causes developmental delays and seizures. 

Dr. Jennifer Downs of Weill Cornell Medicine has spent much of her career in Tanzania, searching for a treatment for schistosomiasis, an acute, chronic parasitic worm infection that affects more than 250 million people worldwide.

The aging liver undergoes dramatic changes in its functional organization and other key attributes, which may underpin its increasing susceptibility to disease, according to a study led by investigators at Weill Cornell Medicine.

A protein called PAR1 helps lymphatic vessels structurally transform to boost fluid drainage and support healing when the lungs are injured according to researchers from Weill Cornell Medicine.

Experts in newest treatment option for cancer, neurological disorders unite to speed progress, expand access.

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators.